Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021

We describe four secondary fungal infections caused by Mucorales species in COVID-19 patients. Three COVID-19 associated mucormycosis (CAM) occurred in ICU, one outside ICU. All were men aged > 50 years, three died. Clinical presentations included pulmonary, rhino-orbital cerebral and disseminate...

Descripción completa

Detalles Bibliográficos
Autores principales: Buil, Jochem B, van Zanten, Arthur R H, Bentvelsen, Robbert G, Rijpstra, Tom A, Goorhuis, Bram, van der Voort, Sanne, Wammes, Linda J., Janson, Jeroen A, Melchers, Max, Heusinkveld, Moniek, Melchers, Willem J G, Kuijper, Ed J, Verweij, Paul E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193993/
https://www.ncbi.nlm.nih.gov/pubmed/34114540
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.23.2100510
_version_ 1783706335102107648
author Buil, Jochem B
van Zanten, Arthur R H
Bentvelsen, Robbert G
Rijpstra, Tom A
Goorhuis, Bram
van der Voort, Sanne
Wammes, Linda J.
Janson, Jeroen A
Melchers, Max
Heusinkveld, Moniek
Melchers, Willem J G
Kuijper, Ed J
Verweij, Paul E
author_facet Buil, Jochem B
van Zanten, Arthur R H
Bentvelsen, Robbert G
Rijpstra, Tom A
Goorhuis, Bram
van der Voort, Sanne
Wammes, Linda J.
Janson, Jeroen A
Melchers, Max
Heusinkveld, Moniek
Melchers, Willem J G
Kuijper, Ed J
Verweij, Paul E
author_sort Buil, Jochem B
collection PubMed
description We describe four secondary fungal infections caused by Mucorales species in COVID-19 patients. Three COVID-19 associated mucormycosis (CAM) occurred in ICU, one outside ICU. All were men aged > 50 years, three died. Clinical presentations included pulmonary, rhino-orbital cerebral and disseminated infection. Infections occurred in patients with and without diabetes mellitus. CAM is an emerging disease and our observations underscore the need to be aware of invasive mucormycosis, including in COVID-19 patients without (poorly controlled) diabetes mellitus and outside ICU.
format Online
Article
Text
id pubmed-8193993
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-81939932021-06-25 Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021 Buil, Jochem B van Zanten, Arthur R H Bentvelsen, Robbert G Rijpstra, Tom A Goorhuis, Bram van der Voort, Sanne Wammes, Linda J. Janson, Jeroen A Melchers, Max Heusinkveld, Moniek Melchers, Willem J G Kuijper, Ed J Verweij, Paul E Euro Surveill Rapid Communication We describe four secondary fungal infections caused by Mucorales species in COVID-19 patients. Three COVID-19 associated mucormycosis (CAM) occurred in ICU, one outside ICU. All were men aged > 50 years, three died. Clinical presentations included pulmonary, rhino-orbital cerebral and disseminated infection. Infections occurred in patients with and without diabetes mellitus. CAM is an emerging disease and our observations underscore the need to be aware of invasive mucormycosis, including in COVID-19 patients without (poorly controlled) diabetes mellitus and outside ICU. European Centre for Disease Prevention and Control (ECDC) 2021-06-10 /pmc/articles/PMC8193993/ /pubmed/34114540 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.23.2100510 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Buil, Jochem B
van Zanten, Arthur R H
Bentvelsen, Robbert G
Rijpstra, Tom A
Goorhuis, Bram
van der Voort, Sanne
Wammes, Linda J.
Janson, Jeroen A
Melchers, Max
Heusinkveld, Moniek
Melchers, Willem J G
Kuijper, Ed J
Verweij, Paul E
Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
title Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
title_full Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
title_fullStr Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
title_full_unstemmed Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
title_short Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
title_sort case series of four secondary mucormycosis infections in covid-19 patients, the netherlands, december 2020 to may 2021
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193993/
https://www.ncbi.nlm.nih.gov/pubmed/34114540
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.23.2100510
work_keys_str_mv AT builjochemb caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT vanzantenarthurrh caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT bentvelsenrobbertg caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT rijpstratoma caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT goorhuisbram caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT vandervoortsanne caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT wammeslindaj caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT jansonjeroena caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT melchersmax caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT heusinkveldmoniek caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT melcherswillemjg caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT kuijperedj caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021
AT verweijpaule caseseriesoffoursecondarymucormycosisinfectionsincovid19patientsthenetherlandsdecember2020tomay2021

Ejemplares similares